Commonly prescribed GLP-1 receptor agonists include semaglutide (sold under brand names like Wegovy and Ozempic) and tirzepatide (marketed as Mounjaro)
These can include nausea, vomiting, diarrhea, and mild abdominal discomfort or dyspepsia
Estrela JM, Ortega A, Mena S, Sirerol JA, Obrador E
The only pathway to override the criteria is a formulary exception request (described above), which has a low success rate and requires the prescriber to argue that the published criteria are inappropriate for the specific patient
This is why many experienced lifters intentionally stay in the 4-8mg range rather than pushing to maximum doses
Central Appetite Regulation: Activation of GLP-1 receptors in the hypothalamus and brainstem decreases hunger and food intake